IREB2, CHRNA5, CHRNA3, FAM13A & HEDGEHOG INTERACTING PROTEIN GENES POLYMORPHISMS &
RISK OF CHRONIC
Chu, Shuk Han,
Zhao, Xu,
Komber, Ahmad,
Cheyne, Joshua,
Wu, Simiao,
Cowey, Eileen,
Kutlubaev, Mansur,
Mead, Gillian (2023) by drug type and sensitivity analysis after excluding the trials at high
risk of bias. Secondary outcomes
Fedorova, Yu. Yu.,
Nurgalieva, A.K.,
Petrova, S.G.,
Murzina, R.R.,
Dzhaubermezov, M.A.,
Ekomasova, N.V.,
Khusnutdinova, E.K.,
Prokofieva, D.S. (2024) , suggesting that hyperho-mocysteinemia is a
risk factor for cholelithiasis. The aim of this work
Torokulova, Karlygach T.,
Biyalieva, Gulmira S.,
Akulich, Elena N.,
Mamytova, Elmira A.,
Mamytova, Aina J.,
Akhmadeeva, Leila R. (2024) in the recovery stage. The stratification of the
risk of developing DVT is crucial when making a decision in terms
predominance of women (64.16%). Lethal outcomes occurred in 62 (35.84%) patients.
Risk factors for lethal
Bai, Ming,
Wang, Xiaolong,
Zhang, Huixue,
Wang, Jianjian,
Lyaysan, Gaysina,
Xu, Si,
Tian, Kuo,
Wang, Tianfeng,
Li, Jie,
Wang, Na,
Lu, Xiaoyu,
Zhang, Xiaoming,
Wang, Lihua (2022) figured out without considering clonal status. These
risk subclonal mutations were associated with some
Balkhiyarova, Z.,
Luciano, R.,
Kaakinen, M.,
Ulrich, A.,
Shmeliov, A.,
Bianchi, M.,
Chioma, L.,
Dallapiccola, B.,
Prokopenko, I.,
Manco, M. (2022) Epidemic obesity is the most important
risk factor for prediabetes and type 2 diabetes (T2D
Nurgalieva, A.Kh.,
Mustafin, S.A.,
Petrova, S.G.,
Ekomasova, N.V.,
Sakaeva, D.D.,
Fedorova, Y.Y.,
Abdeeva, G.R.,
Dzhaubermezov, M.A.,
Abdeev, R.R.,
Rakhimov, R.R.,
Khusnutdinova, E.K.,
Prokofyeva, D.S. (2024) 28362491 of NFKB1 gene with the
risk of GC development for individuals from the Volga-Ural region of Russia